These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15120493)

  • 1. The ups and downs of addiction: role of metabotropic glutamate receptors.
    Kenny PJ; Markou A
    Trends Pharmacol Sci; 2004 May; 25(5):265-72. PubMed ID: 15120493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metabotropic glutamate receptors in drug reward, motivation and dependence.
    Markou A
    Drug News Perspect; 2007 Mar; 20(2):103-8. PubMed ID: 17440633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.
    Moussawi K; Kalivas PW
    Eur J Pharmacol; 2010 Aug; 639(1-3):115-22. PubMed ID: 20371233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.
    Olive MF
    Eur J Pharmacol; 2010 Aug; 639(1-3):47-58. PubMed ID: 20371237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamatergic receptors and their ligands in drug addiction.
    Pomierny-Chamioło L; Rup K; Pomierny B; Niedzielska E; Kalivas PW; Filip M
    Pharmacol Ther; 2014 Jun; 142(3):281-305. PubMed ID: 24362085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group I metabotropic glutamate receptors: involvement in drug-seeking and drug-induced plasticity.
    Bird MK; Lawrence AJ
    Curr Mol Pharmacol; 2009 Jan; 2(1):83-94. PubMed ID: 20021449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness.
    Lesage A; Steckler T
    Eur J Pharmacol; 2010 Aug; 639(1-3):2-16. PubMed ID: 20371230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues.
    Julio-Pieper M; Flor PJ; Dinan TG; Cryan JF
    Pharmacol Rev; 2011 Mar; 63(1):35-58. PubMed ID: 21228260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA; Jane DE
    Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
    Spooren W; Ballard T; Gasparini F; Amalric M; Mutel V; Schreiber R
    Behav Pharmacol; 2003 Jul; 14(4):257-77. PubMed ID: 12838033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of metabotropic glutamate receptors in addiction: evidence from preclinical models.
    Duncan JR; Lawrence AJ
    Pharmacol Biochem Behav; 2012 Feb; 100(4):811-24. PubMed ID: 21443897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia.
    Chaki S
    Eur J Pharmacol; 2010 Aug; 639(1-3):59-66. PubMed ID: 20371240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate and Brain Glutaminases in Drug Addiction.
    Márquez J; Campos-Sandoval JA; Peñalver A; Matés JM; Segura JA; Blanco E; Alonso FJ; de Fonseca FR
    Neurochem Res; 2017 Mar; 42(3):846-857. PubMed ID: 28012058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group III metabotropic glutamate receptors and drug addiction.
    Mao L; Guo M; Jin D; Xue B; Wang JQ
    Front Med; 2013 Dec; 7(4):445-51. PubMed ID: 24078068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
    Cahusac PM; Wan H
    Neuroscience; 2007 Apr; 146(1):202-12. PubMed ID: 17346894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors.
    Dedeurwaerdere S; Boets S; Janssens P; Lavreysen H; Steckler T
    Acta Neurol Belg; 2015 Sep; 115(3):221-32. PubMed ID: 25539775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular basis of addiction.
    Nestler EJ; Aghajanian GK
    Science; 1997 Oct; 278(5335):58-63. PubMed ID: 9311927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between estrogen receptors and metabotropic glutamate receptors and their impact on drug addiction in females.
    Tonn Eisinger KR; Gross KS; Head BP; Mermelstein PG
    Horm Behav; 2018 Aug; 104():130-137. PubMed ID: 29505763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?
    Nicoletti F; Bruno V; Copani A; Casabona G; Knöpfel T
    Trends Neurosci; 1996 Jul; 19(7):267-71. PubMed ID: 8799968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabotropic glutamate receptors: from the workbench to the bedside.
    Nicoletti F; Bockaert J; Collingridge GL; Conn PJ; Ferraguti F; Schoepp DD; Wroblewski JT; Pin JP
    Neuropharmacology; 2011 Jun; 60(7-8):1017-41. PubMed ID: 21036182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.